Staar Surgical (STAA) Gains from Investment Securities (2010 - 2026)

Staar Surgical has reported Gains from Investment Securities for 16 years, with the latest figure at $85000.0 in Q2 2026.

• For the quarter ending Q2 2026, Gains from Investment Securities rose 286.36% year-over-year to $85000.0; the trailing twelve-month figure through Apr 2026 stood at $85000.0 (up 286.36% YoY), and the FY2026 full-year result was $1.7 million, down 38.89% from the prior year.
• Gains from Investment Securities for Q2 2026 stood at $85000.0, down from $102000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $24.9 million in Q4 2022, with the low at $7000.0 in Q2 2022.
• Historically, Gains from Investment Securities has averaged $3.2 million across 5 years, with a median of $112000.0 in 2025.
• Annual changes were most pronounced in 2023 — Gains from Investment Securities soared 41342.86% — and 2024, when it plunged 99.91%.
• Staar Surgical's Gains from Investment Securities stood at $24.9 million in 2022, then tumbled by 40.02% to $14.9 million in 2023, then sank by 99.91% to $13000.0 in 2024, then surged by 14123.08% to $1.8 million in 2025, then tumbled by 95.4% to $85000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $85000.0 (Q2 2026), $102000.0 (Q1 2026), and $1.8 million (Q3 2025), per Business Quant data.